Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991-Reference-Cited by-同舟云学术

Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991

Published:2012-01 Issue:2 Volume:48 Page:218-225
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Eggermont Alexander M.M.,Suciu Stefan,Testori Alessandro,Kruit Wim H.,Marsden Jeremy,Punt Cornelis J.,Santinami Mario,Salès François,Schadendorf Dirk,Patel Poulam,Dummer Reinhard,Robert Caroline,Keilholz Ulrich,Yver Antoine,Spatz Alan

Funder

Fonds Cancer (FOCA)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial;Eggermont;Lancet,2008

2. Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial;Eggermont;Lancet,2005

3. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark’s and Breslow’s staging methods;Balch;Ann Surg,1978

4. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

5. Multivariate analysis of prognostic factors among 2, 313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases;Balch;J Clin Oncol,2010

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world clinical outcome and safety of adjuvant therapy in stage III melanoma patients: Data from two Academic Italian Institutions;International Journal of Cancer;2023-02-21

2. Neoadjuvant treatment for stage III and IV cutaneous melanoma;Cochrane Database of Systematic Reviews;2023-01-17

3. Malignant Melanoma Misdiagnosed as Diabetic Foot Ulcer;The Misdiagnosis Casebook in Clinical Medicine;2023

4. Expert recommendations on diagnostic-therapeutic management of melanoma patients;Oncology in Clinical Practice;2022-12-21

5. Real‐world outcomes using PD ‐1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland;Journal of the European Academy of Dermatology and Venereology;2022-12-12